N-terminal pro-brain natriuretic peptide and adverse outcomes in Chinese patients with hypertrophic cardiomyopathy.

Zeng-Lei ZhangYan-Yan XuZhen QinYong-Zheng LuTian-Ding LiuLi ZhangJia-Hong ShangguanWei WangJun-Nan TangJin-Ying Zhang

Published in: Bioscience reports (2022)

The present study indicated NT-proBNP was a novel biomarker suitable for predicting adverse prognosis in patients with HCM, which may be used for early recognition and risk stratification.

Keyphrases

hypertrophic cardiomyopathy
left ventricular
resting state
anti inflammatory
electronic health record